West Pharmaceutical Services Shares (Diluted) decreased by 0.3% to 72.4M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from 73M to 72.4M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates potential dilution from employee compensation or convertible instruments, which can reduce earnings per share.
The weighted-average number of common shares outstanding plus the effect of all potentially dilutive securities, such as...
Standard metric for all public companies; essential for understanding the impact of equity-based compensation.
weighted_shares_diluted| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 75.7M | 76M | 500K | 76M | 75.8M | 75.7M | 75.7M | 75.4M | 75.3M | 74.3M | 73.7M | 73.4M | 73M | 72.5M | 72.6M | 72.4M |
| QoQ Change | — | +0.4% | -99.3% | >999% | -0.3% | -0.1% | +0.0% | -0.4% | -0.1% | -1.3% | -0.8% | -0.4% | -0.5% | -0.7% | +0.1% | -0.3% |
| YoY Change | — | — | — | — | +0.1% | -0.4% | -0.4% | -0.5% | -0.5% | -1.8% | -2.3% | -2.5% | -1.7% | -1.6% | -1.1% | -0.8% |